Healthcare provider profile · identity verified

Ami M Dose, APRN, FNP

Nurse Practitioner · OTTAWA, IL · NPI 1548429509

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	562	160
Lisinopril	Lisinopril	433	123
Rosuvastatin Calcium	Rosuvastatin Calcium	390	98
Levothyroxine Sodium	Levothyroxine Sodium	317	81
Amlodipine Besylate	Amlodipine Besylate	284	83
Omeprazole	Omeprazole	242	71
Losartan Potassium	Losartan Potassium	222	69
Metformin Hcl	Metformin Hcl	211	59
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	192	29
Gabapentin	Gabapentin	188	55
Hydrochlorothiazide	Hydrochlorothiazide	183	48
Furosemide	Furosemide	168	45
Tramadol Hcl	Tramadol Hcl	138	31
Jardiance	Empagliflozin	133	32
Alprazolam	Alprazolam	131	24
Lorazepam	Lorazepam	129	21
Alendronate Sodium	Alendronate Sodium	123	39
Metoprolol Succinate	Metoprolol Succinate	118	33
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	117	27
Warfarin Sodium	Warfarin Sodium	113	22
Pantoprazole Sodium	Pantoprazole Sodium	111	34
Albuterol Sulfate Hfa	Albuterol Sulfate	104	41
Ozempic	Semaglutide	98	21
Famotidine	Famotidine	97	28
Fluoxetine Hcl	Fluoxetine Hcl	92	21
Eliquis	Apixaban	90	25
Meloxicam	Meloxicam	89	24
Montelukast Sodium	Montelukast Sodium	86	22
Carvedilol	Carvedilol	84	24
Mounjaro	Tirzepatide	84	19
Escitalopram Oxalate	Escitalopram Oxalate	83	27
Tamsulosin Hcl	Tamsulosin Hcl	82	27
Metoprolol Tartrate	Metoprolol Tartrate	81	20
Fluticasone Propionate	Fluticasone Propionate	78	24
Simvastatin	Simvastatin	77	18
Metformin Hcl Er	Metformin Hcl	76	22
Allopurinol	Allopurinol	70	22
Duloxetine Hcl	Duloxetine Hcl	61	17
Prednisone	Prednisone	60	33
Trazodone Hcl	Trazodone Hcl	55	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	17
Potassium Chloride	Potassium Chloride	54	22
Hydralazine Hcl	Hydralazine Hcl	49	12
Pravastatin Sodium	Pravastatin Sodium	48	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	16
Topiramate	Topiramate	45	12
Olanzapine	Olanzapine	42	suppressed
Breo Ellipta	Fluticasone/Vilanterol	41	suppressed
Pregabalin	Pregabalin	41	suppressed
Sertraline Hcl	Sertraline Hcl	41	13
Trulicity	Dulaglutide	41	suppressed
Xarelto	Rivaroxaban	41	13
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Ezetimibe	Ezetimibe	40	15
Oxybutynin Chloride Er	Oxybutynin Chloride	40	11
Spironolactone	Spironolactone	40	13
Ropinirole Hcl	Ropinirole Hcl	38	suppressed
Symbicort	Budesonide/Formoterol Fumarate	37	suppressed
Atenolol	Atenolol	35	suppressed
Ondansetron Hcl	Ondansetron Hcl	35	14
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	18
Naproxen	Naproxen	32	11
Rybelsus	Semaglutide	31	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	31	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	30	suppressed
Enalapril Maleate	Enalapril Maleate	30	suppressed
Donepezil Hcl	Donepezil Hcl	29	suppressed
Bupropion Xl	Bupropion Hcl	28	11
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Methylprednisolone	Methylprednisolone	27	23
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	26	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Glimepiride	Glimepiride	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Cephalexin	Cephalexin	25	20
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	11
Propranolol Hcl	Propranolol Hcl	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Klor-Con M20	Potassium Chloride	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Levonorgestrel-Eth Estradiol	Levonorgestrel/Ethin.Estradiol	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Spiriva Handihaler	Tiotropium Bromide	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	13
Fenofibrate	Fenofibrate	16	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Valsartan	Valsartan	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	suppressed
Baclofen	Baclofen	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	12
Ramipril	Ramipril	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Glipizide	Glipizide	12	suppressed
Humalog	Insulin Lispro	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Nystatin	Nystatin	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Tiadylt Er	Diltiazem Hcl	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error